Effects of systemic versus local administration of corticosteroids on mucosal tolerance

Journal of Immunology

Volumn 188, Issue 1, 2012, Pages 472-476

  Kerzerho, Jerome ^a   Wunsch, Daniela ^b   Szely, Natacha ^a   Meyer, Hellmuth Alexander ^b   Lurz, Lisa ^b   Röse, Lars ^c   Wahn, Ulrich ^b   Akbari, Omid ^a   Stock, Philippe ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c BAYER PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CD3 ANTIGEN; CD4 ANTIGEN; CORTICOSTEROID; DEXAMETHASONE; IMMUNOGLOBULIN E; INTERLEUKIN 2 RECEPTOR ALPHA; PREDNISOLONE; TRANSCRIPTION FACTOR FOXP3;

ADOPTIVE TRANSFER; AIRWAY; AIRWAY HYPERACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MEGADOSE; EFFECTOR CELL; EXPOSURE; FEMALE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGICAL TOLERANCE; LOW DRUG DOSE; LUNG FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; MUCOSAL TOLERANCE; MUCUS SECRETION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RESPIRATORY TOLERANCE; SPLEEN; TH2 CELL; ANIMAL; ASTHMA; BAGG ALBINO MOUSE; CELL PROLIFERATION; DISEASE MODEL; DRUG EFFECT; HUMAN; IMMUNOLOGY; MUCOSAL IMMUNITY;

ADRENAL CORTEX HORMONES; ALLERGENS; ANIMALS; ASTHMA; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES, REGULATORY; TH2 CELLS;

EID: 84855391238     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101405     Document Type: Article

References (39)

1. Barnes, P. J., S. Pedersen, and W. W. Busse. 1998. Efficacy and safety of inhaled corticosteroids: new developments. Am. J. Respir. Crit. Care Med. 157: S1-S53. (Pubitemid 28125600)
2. Bentley, A. M., Q. Hamid, D. S. Robinson, E. Schotman, Q. Meng, B. Assoufi, A. B. Kay, and S. R. Durham. 1996. Prednisolone treatment in asthma: reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa. Am. J. Respir. Crit. Care Med. 153: 551-556.
3. Gauvreau, G. M., J. Doctor, R. M. Watson, M. Jordana, and P. M. O'Byrne. 1996. Effects of inhaled budesonide on allergen-induced airway responses and airway inflammation. Am. J. Respir. Crit. Care Med. 154: 1267-1271. (Pubitemid 26391167)
4. Blotta, M. H., R. H. DeKruyff, and D. T. Umetsu. 1997. Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. J. Immunol. 158: 5589-5595. (Pubitemid 127483960)
5. DeKruyff, R. H., Y. Fang, and D. T. Umetsu. 1998. Corticosteroids enhance the capacity of macrophages to induce Th2 cytokine synthesis in CD4+ lymphocytes by inhibiting IL-12 production. J. Immunol. 160: 2231-2237. (Pubitemid 28119903)
6. Fox, G. F., M. L. Everard, M. J. Marsh, and A. D. Milner. 1999. Randomised controlled trial of budesonide for the prevention of post-bronchiolitis wheezing. Arch. Dis. Child. 80: 343-347. (Pubitemid 29164758)
7. Wiley, R. E., M. Cwiartka, D. Alvarez, D. C. Mackenzie, J. R. Johnson, S. Goncharova, L. Lundblad, and M. Jordana. 2004. Transient corticosteroid treatment permanently amplifies the Th2 response in a murine model of asthma. J. Immunol. 172: 4995-5005. (Pubitemid 38456426)
8. Akbari, O., G. J. Freeman, E. H. Meyer, E. A. Greenfield, T. T. Chang, A. H. Sharpe, G. Berry, R. H. DeKruyff, and D. T. Umetsu. 2002. Antigenspecific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 8: 1024-1032. (Pubitemid 35033708)
9. Stock, P., O. Akbari, G. Berry, G. J. Freeman, R. H. Dekruyff, and D. T. Umetsu. 2004. Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nat. Immunol. 5: 1149-1156. (Pubitemid 39549629)
10. Stock, P., O. Akbari, R. H. DeKruyff, and D. T. Umetsu. 2005. Respiratory tolerance is inhibited by the administration of corticosteroids. J. Immunol. 175: 7380-7387. (Pubitemid 41713435)
11. Akbari, O., P. Stock, E. Meyer, M. Kronenberg, S. Sidobre, T. Nakayama, M. Taniguchi, M. J. Grusby, R. H. DeKruyff, and D. T. Umetsu. 2003. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergeninduced airway hyperreactivity. Nat. Med. 9: 582-588. (Pubitemid 36597105)
12. Lombardi, V., P. Stock, A. K. Singh, J. Kerzerho, W. Yang, B. A. Sullivan, X. Li, T. Shiratsuchi, N. E. Hnatiuk, A. R. Howell, et al. 2010. A CD1d-dependent antagonist inhibits the activation of invariant NKT cells and prevents development of allergen-induced airway hyperreactivity. J. Immunol. 184: 2107-2115.
13. Hamelmann, E., A. T. Vella, A. Oshiba, J. W. Kappler, P. Marrack, and E. W. Gelfand. 1997. Allergic airway sensitization induces T cell activation but not airway hyperresponsiveness in B cell-deficient mice. Proc. Natl. Acad. Sci. USA 94: 1350-1355. (Pubitemid 27087854)
14. Akbari, O., R. H. DeKruyff, and D. T. Umetsu. 2001. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2: 725-731. (Pubitemid 32747162)
15. Prod'homme, T., M. S. Weber, and S. S. Zamvil. 2007. T effectors outfox T regulators in autoimmunity. Nat. Med. 13: 411-413. (Pubitemid 46559819)
16. Akdis, M., J. Verhagen, A. Taylor, F. Karamloo, C. Karagiannidis, R. Crameri, S. Thunberg, G. Deniz, R. Valenta, H. Fiebig, et al. 2004. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J. Exp. Med. 199: 1567-1575. (Pubitemid 38780411)
17. Seymour, B. W., L. J. Gershwin, and R. L. Coffman. 1998. Aerosol-induced immunoglobulin (Ig)-E unresponsiveness to ovalbumin does not require CD8+ or T cell receptor (TCR)-gamma/delta+ T cells or interferon (IFN)-gamma in a murine model of allergen sensitization. J. Exp. Med. 187: 721-731. (Pubitemid 28115188)
18. John, M., S. Lim, J. Seybold, P. Jose, A. Robichaud, B. O'Connor, P. J. Barnes, and K. F. Chung. 1998. Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma. Am. J. Respir. Crit. Care Med. 157: 256-262. (Pubitemid 28071290)
19. Adams, N. P., J. C. Bestall, T. J. Lasserson, and P. W. Jones. 2005. Inhaled fluticasone versus placebo for chronic asthma in adults and children. Cochrane Database Syst. Rev. (2):): CD003135.
20. Uings, I. J., and S. N. Farrow. 2005. A pharmacological approach to enhancing the therapeutic index of corticosteroids in airway inflammatory disease. Curr. Opin. Pharmacol. 5: 221-226. (Pubitemid 40674242)
21. Jabara, H. H., D. J. Ahern, D. Vercelli, and R. S. Geha. 1991. Hydrocortisone and IL-4 induce IgE isotype switching in human B cells. J. Immunol. 147: 1557-1560.
22. Jabara, H. H., R. Loh, N. Ramesh, D. Vercelli, and R. S. Geha. 1993. Sequential switching from mu to epsilon via gamma 4 in human B cells stimulated with IL- 4 and hydrocortisone. J. Immunol. 151: 4528-4533. (Pubitemid 23318506)
23. Jabara, H. H., S. R. Brodeur, and R. S. Geha. 2001. Glucocorticoids upregulate CD40 ligand expression and induce CD40L-dependent immunoglobulin isotype switching. J. Clin. Invest. 107: 371-378. (Pubitemid 32157969)
24. Nüsslein, H. G., G. Weber, and J. R. Kalden. 1994. Synthetic glucocorticoids potentiate IgE synthesis: influence of steroid and nonsteroid hormones on human in vitro IgE secretion. Allergy 49: 365-370. (Pubitemid 24163868)
25. Wu, C. Y., C. Fargeas, T. Nakajima, and G. Delespesse. 1991. Glucocorticoids suppress the production of interleukin 4 by human lymphocytes. Eur. J. Immunol. 21: 2645-2647.
26. Settipane, G. A., R. K. Pudupakkam, and J. H. McGowan. 1978. Corticosteroid effect on immunoglobulins. J. Allergy Clin. Immunol. 62: 162-166. (Pubitemid 9018208)
27. Zieg, G., G. Lack, R. J. Harbeck, E. W. Gelfand, and D. Y. Leung. 1994. In vivo effects of glucocorticoids on IgE production. J. Allergy Clin. Immunol. 94: 222-230.
28. Bellinghausen, I., U. Brand, K. Steinbrink, A. H. Enk, J. Knop, and J. Saloga. 2001. Inhibition of human allergic T-cell responses by IL-10-treated dendritic cells: differences from hydrocortisone-treated dendritic cells. J. Allergy Clin. Immunol. 108: 242-249. (Pubitemid 32735408)
29. Canning, M. O., K. Grotenhuis, H. J. de Wit, and H. A. Drexhage. 2000. Opposing effects of dehydroepiandrosterone and dexamethasone on the generation of monocyte-derived dendritic cells. Eur. J. Endocrinol. 143: 687-695.
30. de Jong, E. C., P. L. Vieira, P. Kalinski, and M. L. Kapsenberg. 1999. Corticosteroids inhibit the production of inflammatory mediators in immature monocyte-derived DC and induce the development of tolerogenic DC3. J. Leukoc. Biol. 66: 201-204. (Pubitemid 29379155)
31. Rea, D., C. van Kooten, K. E. van Meijgaarden, T. H. Ottenhoff, C. J. Melief, and R. Offringa. 2000. Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10. Blood 95: 3162-3167. (Pubitemid 30321168)
32. Vieira, P. L., P. Kaliński, E. A. Wierenga, M. L. Kapsenberg, and E. C. de Jong. 1998. Glucocorticoids inhibit bioactive IL-12p70 production by in vitrogenerated human dendritic cells without affecting their T cell stimulatory potential. J. Immunol. 161: 5245-5251. (Pubitemid 28519083)
33. Visser, J., A. van Boxel-Dezaire, D. Methorst, T. Brunt, E. R. de Kloet, and L. Nagelkerken. 1998. Differential regulation of interleukin-10 (IL-10) and IL-12 by glucocorticoids in vitro. Blood 91: 4255-4264. (Pubitemid 28261990)
34. Miyaura, H., and M. Iwata. 2002. Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids. J. Immunol. 168: 1087-1094. (Pubitemid 34094472)
35. Hemady, Z., S. Gellis, M. Chambers, and R. E. Rocklin. 1985. Effect of dexamethasone on de novo IgE synthesis by human blood lymphocytes. J. Allergy Clin. Immunol. 75: 304-312. (Pubitemid 15239086)
36. Karagiannidis, C., M. Akdis, P. Holopainen, N. J. Woolley, G. Hense, B. Rückert, P. Y. Mantel, G. Menz, C. A. Akdis, K. Blaser, and C. B. Schmidt- Weber. 2004. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J. Allergy Clin. Immunol. 114: 1425-1433. (Pubitemid 39575901)
37. Newman, S. P., D. Pavia, F. Morén, N. F. Sheahan, and S. W. Clarke. 1981. Deposition of pressurised aerosols in the human respiratory tract. Thorax 36: 52-55. (Pubitemid 11188675)
38. Möller, C., S. Dreborg, H. A. Ferdousi, S. Halken, A. Høst, L. Jacobsen, A. Koivikko, D. Y. Koller, B. Niggemann, L. A. Norberg, et al. 2002. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J. Allergy Clin. Immunol. 109: 251-256. (Pubitemid 34158289)
39. Umetsu, D. T., O. Akbari, and R. H. Dekruyff. 2003. Regulatory T cells control the development of allergic disease and asthma. J. Allergy Clin. Immunol. 112: 480-487, quiz 488.